Recent Company News

• 11:24 AM ET Jul 14, 2026
  

  StreetAccount Summary - US unusual volume traders

• 09:15 AM ET Aug 03, 2026
  

  StreetAccount Summary - US Pre-market trading update

• 07:20 AM ET Aug 03, 2026
  

  Autolus Therapeutics reports preliminary Q2 2026 net product revenue; announces credit facility of up to $250M with Perceptive Advisors ($1.49, 0.00)

• 09:51 AM ET Jun 30, 2026
  

  Transcript Intelligence: Autolus Therapeutics at HC Wainwright Cell Therapy Virtual Conference ($1.65, 0.00)

• 12:07 PM ET Jun 03, 2026
  

  Transcript Intelligence: Autolus Therapeutics at William Blair Growth Stock Conference

• 12:07 PM ET Jun 03, 2026
  

  Transcript Intelligence : Autolus Therapeutics à la conférence William Blair Growth Stock

• 11:33 AM ET Jun 03, 2026
  

  Transcript Intelligence: Autolus Therapeutics at Jefferies Global Healthcare Conference ($1.69, -0.07)

• 10:04 AM ET Jun 02, 2026
  

  FDA issues draft guidance to help accelerate cell and gene therapies for patients - fda.gov

• 05:16 PM ET May 21, 2026
  

  Autolus Therapeutics to present clinical data update at ASCO annual meeting 2026 ($1.65, 0.00)